UK Innovation Revolutionizes Global Type 2 Diabetes Treatment: Study Shows
Advertisement
Millions of people with type 2 diabetes could receive better treatment thanks to a new, simple low-cost tool, according to groundbreaking research announced at the Diabetes UK Professional Conference 2025 and published in the Lancet.
Researchers at the University of Exeter have developed an innovative way of identifying the most effective glucose-lowering drugs for a person with type 2 diabetes. By predicting which drug will lead to the largest reduction in blood glucose levels, the easy-to-use tool could pave the way for better health for millions, at the push of a button. Careful management of blood glucose levels is essential for reducing the risk of serious diabetes complications. However, keeping blood glucose levels in a safe range can be challenging, with only about a third of people with type 2 diabetes meeting targets. With diabetes-related complications devastating lives there is an urgent need for new approaches to improve blood glucose management.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.